We began taking a look at MBHC yesterday, mostly focusing upon the strong additions to management, and the extreme promise pertaining to the company’s news of a global deal signed with Twitter. We did however, publish a video highlighting some of the key points on the chart, and that’s what we’re going to focus on to start things off today.
The stock would make a handful of intraday moves on almost twice the monthly average volume. Early on we saw a run from .0042-.0057 (+36%), followed by two separate subsequent swings from .0041-.0053 (+29%).
Most importantly the stock recorded a higher low, holding support above 50DMA of .004 as we’d hoped for, and we want to continue to see it maintained above that level. Moving forward, we’ll be looking out for a breach of the resistance that cropped up at .006 .
Stocks on Bottom-Watch
The following four plays have been getting beat up pretty bad of late, and whenever we notice stocks in this position, we like to relegate them to a potential bottom-play watchlist. Some of the biggest rapid moves we witness come from course-correction related bounces, so we’ll have these stocks on our recovery watchlist moving forward:
BTDG is a momentum-play that we’re going to be monitoring as we head into mid-week, and we’ve gone ahead and pointed out the reasoning behind this on the following chart snapshot. Yesterday brought a break of a key resistance point and with a number of other bullish indicators are leading us to give BTDG part of our attention.
We’re going to start off this new trading week with a new item of interest in MBHC, a stock with an interesting backstory that began to build some nice momentum on the chart toward the end of last week.
The main focus of the company at the moment is the impending launch of its new mobile streaming app, known as Whirld. It is intended to be the first truly real-time, interactive, mobile video broadcasting utility, and has been approved for sale in the Apple APP Store (iOS) and the Google Play Market (Android).
The launch was originally slated for late this spring, but was temporarily delayed for extra time in beta testing, and to upgrade to a global communications platform that will allow for more expedient updates and enhancements once the app is in operation. Per the release which revealed that announcement, we are now less than a month away from seeing all of the necessary changes implemented and having the app hit stores.
To facilitate all of the progressive changes at the company and give the Whirld app its best chance for success, MBHC brought in two industry heavyweights with the collective knowledge to get it off the ground; Jeff Marcus, and Alan Rambam.
Jeff Marcus has had his hand in billions of dollars worth of IT startups over the years, building himself an extremely impressive resume`. From his early days as a software engineer for IBM and formulating network solutions for UPS and KPMG, he began accruing the knowledge required for an ambitious endeavor such as the Whirld app. His career led him to high-level networking positions at companies like 24/7 Real Media (sold for $650M) and DoubleClick (Google buyout totaling $3.1B). He’s had a front-row seat for the development of the mobile age, and brings all of that experience and know-how to MBHC.
Alan Rambam is a social media, advertising, and analytics expert who previous job experience file is also jam-packed. He was one of the youngest staff members in the Clinton Administration, and would go on to found Shine, Inc. were he would develop well-known social campaigns and charities such as the MTV Fight for Your Rights Campaign, and the Muhammad Ali Scholarship Fund.
On Friday, MBHC enjoyed a surge in momentum in the wake of an exciting press release that really ramps up Whirld’s extreme potential as an app. In an global deal signed with none other than Twitter, MBHC has secured itself as the the home for Electronic Dance Music (EDM), a rapidly growing genre,to provide the most shared, real-time EDM concert footage on Earth. It includes unfettered access to air in real-time every piece of content placed on Twitter from some of the worlds biggest EDM Festivals (including Tomorrowland, Electric Daisy Festival, Ultra, and Electric Zoo). This is a significant proposition, with EDM Festivals raking in roughly $4.5B annually; no other genre of festival music in the world can make such a claim. EDM has a huge following in the younger generation, which is a key demographic being targeted by MBHC for the Whirld app. >>> VIEW PR
As we said, the MBHC chart has also recently awakened, with a good bit of momentum building up at the end of last week. We’ve prepared a corresponding video presentation for your viewing convenience:
Those of our followers who participate in our daily live traders chats were given advanced notice on our call of MBHC as you can see by the following screen snap taken right at the market open. Those participants had a chance at up to 172% in intraday gains as the stock ran from .0039-.0106. It was a great example of why we freely invite all of our subscribers to take part in these daily Skype-facilitated chats. Just send a contact request to username ‘stocksumo’ to join in!
Options Recap – Friday’s Huge Winner
We can’t go without mentioning the top-notch options ideas we offered our readers in Friday’s premarket report. In the midst of taking credit for the previous session’s ideas we had on NFLX (One of which ran more than 3800% in a single session!) we presented GOOG as a good options-trading candidate and recorded a target range. Specifically, we called attention to GOOG Weekly $640-655 Calls. As everyone should be aware, GOOG had a landmark session after the earnings beat;
impressively gaining more than 16% as it traded in a range from 645.00 – 674.47.
As a result, and for the second consecutive day, our options ideas went haywire and yielded up the chance at some excellent profits. Here’s a breakdown of the moves that were made by those hot-ticket contracts:
$640 Calls – Daily Range: 8.80-29.00 – Max Gain: 230% $642.50 Calls – Daily Range: 9.40-27.40 – Max Gain: 191% $645 Calls – Daily Range: 6.20-24.90 – Max Gain: 302% $650 Calls – Daily Range: 3.90-23.56 – Max Gain: 302% $655 Calls – Daily Range: 2.33-18.50 – Max Gain: 694%
For your convenience, we also prepared a video highlighting the great moves we saw as well, so check it out below, and have a great start to the week!
TBIO was included in yesterday’s morning report, and the stock recorded a notable session with the help of a favorable press release. The stock started out from an early low of 1.58, and ran 29% to 2.04, dipped back to 1.77 before going on to hit its high of day at 2.11, an added 19% swing. Volume was immense, to the tune of more than nine times the 3-month average.
The news release from yesterday was pertaining to the company’s claim that they’ve developed the most comprehensive test to date for the diagnosis of Leukodystrophy, a disorder that has been notoriously difficult to diagnose; in many cases taking years. >>VIEW PR
There are a number of attractive features of the TBIO chart even after the considerable run it has enjoyed over the past few days- The strengthening RSI just broke the 50-line, and the MACD is gearing up for a bullish cross.
We’ll look for TBIO to continue registering higher lows, preferably above the 50DMA of 1.76, and for it to test resistance in the channel between yesterday’s high of 2.11 and the 200DMA of 2.15. TBIO certainly has a history of making breakout-type moves; twice this year the stock has traded for more than 3.50.
We’ve identified a couple of fresh options ideas to pass along to our readers this morning. For each of the following movers, we’ll be on the lookout for the occurrence of a dip-and-rip scenario Both stocks are gapping up here in the premarket.
FitBit, Inc. FIT
For FIT, we are going to monitor Weekly Calls (Friday Expiration) in the $45.50-48 range. We want to pay close attention to them the next couple of sessions as FIT has been establishing higher highs and higher lows on the chart. We’re watching for a dip from profit-taking, and subsequent rebound. If and when that happens, we should see some nice action in the range we highlighted.
Netflix, Inc. NFLX
As for NFLX, which has brought us serious options trading success in the past, we’re going to look for chances in Weekly Calls priced from $100-105. The stock just underwent a forward split, and there is some precedent for price increases following such an event (e.g. AAPL).
We’ve got a news play hitting our scanner this morning in SPCL, and as it turns out, the chart is looking ripe for a nice move. As we’ve pointed out on the following snapshot, the stock is trading near a relative bottom, having just registered a new 52-week low just two weeks ago.
Our regular readers are well acquainted with our history of banking excellent gains off a good rebound play. SPCL could be next in line on that front, so we’ll keep a sharp eye on it to start the week.
In addition to trading near a bottom, we’re seeing signs of a very oversold stock with a lot of room to the upside:
PALM SPRINGS, Calif., July 13, 2015 (GLOBE NEWSWIRE) — Solaris Power Cells, Inc. the creators of the Solaris PESATM “Passive Electron Storage Array”™, (the “Company”) (OTCQB:SPCL) the Board of Directors of Solaris Power Cells today announced the appointment of long-time energy policy leader Robert Foster to lead Solaris Energy Storage Advisory Board, effective July 10th 2015. >> FULL PR
OncoGenex Pharmaceuticals, Inc OGXI
OGXI announced this morning that one of its cancer treatments, currently in Phase III trials has passed rigorous criteria and
that trials for patients with non-small cell lung cancer will proceed as planned. The stock is gapping up in premarket trading, and we’re going to monitor its activity as the session commences.
BOTHELL, Wash. and VANCOUVER, British Columbia, July 13, 2015 /PRNewswire/ — OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that its Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) is continuing as planned per the recommendation of an Independent Data Monitoring Committee>> FULL PR
Frontline, Ltd. FRO
We’ve got a long history with FRO that stretches all the way back to 2012. We tagged FRO in Thursday’s premarket report, after it hit a relative bottom of 2.21 on Wednesday. Our observed low following Thursday’s alert was 2.32, and on Friday we saw as the stock inched up to a high of 2.43. We’re going to be on the lookout for further gains; the stock is gapping up slightly in early trading this morning.
An added element to the story is an opinion article that came across the wires last week pertaining to the perceived undervaluation of FRO. It points to a potential longer-term uptrend in the cards, stating that while this year’s earnings growth is expected to top last year’s by more than 200%, that hasn’t really been reflected in the share price. We suggest our subscribers click the following link and give it a read >> VIEW ARTICLE
To start things off this morning we wanted to provide an update on DRMC, which made an excellent intraday move to start the session yesterday.
When last we looked in on DRMC at the end of the short week on Thursday, we had just observed a decent 35% intraday run in the prior session, and left our readers with a closing thought that would end up serving us well. We noted that the stock had been trading relatively thinly as a general rule, and that “a pickup in buying pressure could really send DRMC for a ride, so we’ll keep watch for that, and for the stock to continue maintaining support above the 50DMA”
It’s a good thing that we did keep watch, because the stock would both maintain above the 50DMA (.002), and see the necessary surge in volume to make its mark. Starting out from a morning low of .0037, DRMC bulled its way up to a high of .0079 in roughly the first 45 minutes of trading. That worked out to an incredible single session rip totaling 113% From our observed low on Tuesday (.0022), yesterday’s high registered as a two-session swing of 259%
The excellent spike in volume came in conjunction with the company’s announcement that it was adding Carbon Fiber to its list of manufacturing technologies, as well as launching its new website. >>View PR
Regen BioPharma, Inc. RGBP
RGBP is hitting our scanner this morning for a couple of reasons. Firstly, the company released a positive PR regarding one of its new drug candidates, HemaXellerate. The results of an animal study conducted at the behest of the FDA proved promising with regard to the treatment’s path to approval for clinical trials.
Secondly, RGBP represents a potential opportunity as a play trading near a recent relative bottom. We’re going to look for RGBP to record higher highs and higher lows. and hold support above Tuesday’s swing low of .12 in order for us to remain interested.
